Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by PowerofNowon Jun 09, 2020 4:43am

201 Views

Post# 31127458

Such a scam; c-19 and this 🇮🇱 stock☠

Whoever is still holding here must wake up to the fact that the CDC announced the death rate of Coronavirus patients to be .026-.04% at most. That's when I sold after this fact. Since selling at .11 the stocks plunged to .075 cents. If and when the vaccine comes out I'll buy in for all the drone bots ready to get vaxed.

<< Previous

Bullboard Posts

Next >>

Fortuna reports record earnings for Q3 2024